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The Hampton Roads Sanitation District (HRSD) conducted pilot-feasibility studies to reclaim its 
municipal wastewater for indirect potable reuse by groundwater recharge via direct aquifer 
injection. Reclaimed water for potable reuse requires consideration of its microbial quality. 
Human enteric virus pathogens, specifically adenovirus, reovirus, and enterovirus, found in 
wastewater are of health concern and are culturable in mammalian cell cultures. Traditionally, 
cell culture techniques are used detect the presence and concentrations of viruses in 
environmental samples. However, these methods often require long incubation periods before 
viruses may replicate and show visible signs of infection. Molecular methods, such as 
polymerase chain reaction (PCR), facilitate direct and more sensitive and specific assays to 
detect human enteric viruses in the environment but they rely solely on amplified nucleic acid 
signals and do not distinguish between viable, infectious viruses and genes from non-infectious 
viruses.  Integrated cell culture plus RT-qPCR (ICC-PCR) provides sensitive and specific detection 
of culturable, infectious viruses even in the absence of visible effects of virus infectivity. 
Significant reductions in concentrations of infectious human adeno-, reo- and possibly 
enterovirus viruses by ICC-PCR were found between initial raw sewage influent and the final 
reclaimed water (p-value < 0.05) of the HRSD reclaimed water reclamation train based on 5 
monthly sets of samples. Reclaimed water virus reductions were similar to those of the HRSD 
conventional wastewater treatment train. The calculated log10 virus reductions did not meet 
the 12-log10 reduction performance target set by California or the 5-log10 reduction 
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As the population of the world continues to grow, a rapid increase in the rate of urbanization 
has resulted in recent decades. Worldwide, the percentage of people living in urban areas has 
increased from 30 percent in 1950, to 55 percent in 2018 (United Nations, 2018). North 
America is currently the most urbanized region of the world, with an estimated 82 percent of 
the population residing in an urban area (United Nations, 2018).  
This increased rate of urbanization has resulted in higher concentrations of people living within 
urban settlements. The population growth of urban areas has increased the demand for safe 
drinking water from freshwater sources (McDonald et al., 2011). As people continue to move 
into urban settlements, there is concern that this concentration of people within limited 
geographic regions will continue to place strain on stressed freshwater sources. This issue is 
particularly challenging as most freshwater sources are already experiencing water stress 
(Vörösmarty et al., 2010). 
Central to all urban settlements is a water supply system (Marlow, Moglia, Cook, & Beale, 
2013). The availability and reliability of these water supply systems is facing growing pressure 
and stress from population growth, urbanization, and the impacts of climate change 
(Vörösmarty et al., 2010). The majority of water-supply systems rely on a linear “once-through” 
approach (Anderson, 2003). Under a “once-through” approach, water is withdrawn from a fresh 
water source and, once the customer has used the water, it is released as treated or untreated 




This type of “once-through” water management practice does not provide recharge of the 
original water sources other than through natural processes. In areas where the rate of 
withdrawal is higher than the rate of natural recharge, there is a net loss of water in that 
freshwater source (Anderson, 2003). This is of major concern to cities worldwide as they may 
experience depletion of aquifers as well as increased demands on surface water sources as they 
continue to urbanize.  
It is estimated that by 2050, 66% of the world’s population will live in an urban area (United 
Nations, 2018). Furthermore, 89 countries will have urbanization rates exceeding 80% of its 
population (United Nations, 2018). It is imperative for cities worldwide to adopt robust, 
reliable, and resilient water management practices to alleviate the increasing threat of 
urbanization, population growth, and climate change on water supply systems.  
A practice that has been increasing in use in the last few decades is the use of recycled water. 
Recycled water refers to the intended use of treated wastewater effluent for both potable and 
non-potable purposes (Water Reuse, 2012). The use of recycled water for non-potable reuses, 
such as agriculture, park and golf course maintenance, and industrial reuse has been 
documented for nearly a century. The first use of recycled water for large-scale potable reuse 
dates back to the 1960’s (Asano, Burton, Leverenz, Tsuchihashi, & Tchobanoglous, 2007).  
Potable reuse can be divided into two distinct practices, indirect potable reuse and direct 
potable reuse. Direct potable reuse involves the introduction of highly treated water directly 




potable reuse introduces the highly treated water into a natural environmental buffer for a 
period of time and is then withdrawn for further drinking water treatment (EPA, 2012).   
Concerns that arise with recycled water include the possibility of microbial and chemical 
sources of contamination in the water. Biological contaminants of concern include bacteria 
such as Salmonella spp., Campylobacter spp., Clostridium perfringens and pathogenic 
Escherichia coli; protozoa such as Cryptosporidium spp. and Giardia lamblia; and lastly, viruses 
such as Adenoviridae (adenoviruses), Caliciviridae (noroviruses), Picornaviridae (enteroviruses), 
and Reoviridae (rotaviruses and reoviruses) (WHO, 2017). Viruses are of major concern as they 
are present in wastewater in high numbers (up to 106 per liter) and have low infectious doses 
(Charles P Gerba, Betancourt, & Kitajima, 2017; WHO, 2017). There are currently no federal 
guidelines that exist to regulate the use of treated wastewater intended for potable reuse, and 
the regulations that do exist, vary vastly among different US states (EPA, 2017). 
A duty of public drinking water providers is to ensure that their drinking water supply does not 
harm the public health of the community they serve. The framework for safe drinking water 
developed by the WHO is shown in figure 1. A key element in the framework for safe drinking 
water includes a system assessment of the water reclamation train (WHO, 2017). This system 
assessment includes an analysis on the microbial, chemical, radiological, and acceptability 





Figure 1. Framework for safe drinking water (WHO, 2017). 
Many public drinking water providers are considering recycled water as a way to address water 
stress and to protect water resources for future generations. In particular, the Hampton Roads 
Sanitation District (HRSD) in Virginia has begun a pilot program known as “SWIFT” (Sustainable 
Water For Tomorrow) to explore options for wastewater reuse. Performance testing of two 
candidate wastewater reclamation treatment trains for indirect potable reuse by groundwater 
recharge via direct aquifer injection has been started by the sanitation district. These two 
wastewater reclamation trains include treatment methods that are either membrane-based, or 
carbon-based advanced water treatment technologies. As a public drinking water provider, 
HRSD has a commitment to ensure the recycled water they are injecting back into the Potomac 
Aquifer meets certain biological and chemical quality standards. The purpose of this research is 
to provide the sanitation district with information regarding the occurrence and concentrations 
of infectious human enteric viruses present within their wastewater and carbon-based pilot 






The purpose of this research was to detect and quantify the concentrations of infectious human 
enteric viruses, specifically reovirus, enterovirus, adenovirus, in a 10 thousand gallon per day 
(GPD) carbon-based advanced wastewater treatment facility pilot site for indirect potable reuse 
by groundwater recharge via direct injection. This research will contribute to the development 
of a protocol for the detection and quantification of human enteric virus by integrated cell 
culture plus RT-qPCR (ICC-RT-qPCR) in advanced wastewater treatment systems as well as 
inform the sanitation district of the virological performance of their candidate water 
reclamation treatment trains.  
BACKGROUND AND REVIEW OF THE LITERATURE 
 
Water Reuse 
The concentration of humans within urban settlement and the improvements in the quality of 
life have resulted in an increased strain on available water sources. As of 2018, it is estimated 
that 82.3 percent of the population of the United States lives within an urban area, with the 
percentage projected to increase to 89.2 percent by 2050 (United Nations, 2018). This growth, 
coupled with unsustainable water management practices has resulted in alterations of the 
natural water cycle, where rates of withdrawal are higher than the rates of replenishment of 
local water sources (Anderson, 2003). 
In 2015, 39 percent of potable water provided by public water supplies in the United States 




supplies operate under a “once through” approach. By using this approach, groundwater or 
surface water is withdrawn as a source of drinking water, treated and distributed to the public, 
and then managed as wastewater before being discharged into a separate source of water, 
often a surface water. A concern associated with the use of a “once through” approach is that 
used water is discharged in a way that prevents recharging of the aquifers or surface waters 
from which it was originally withdrawn. This concern is of particular interest for areas 
experiencing water stress.  
A way to combat water stress is through the implementation of water reuse through water 
reclamation systems. Reclaimed water is defined as municipal wastewater that has been 
treated to meet specific water quality criteria with the intent of being used for a range of 
beneficial purposes (EPA, 2012). Reclaimed water can be used for potable applications, which 
can be categorized into two distinct usage strategies- indirect potable reuse (IPR), and direct 
potable reuse (DPR). Indirect potable reuse refers to the indirect augmentation of a drinking 
water source with reclaimed water through the use of an environmental buffer preceding 
conventional drinking water treatment (EPA, 2012). Direct potable reuse refers to the direct 
introduction of reclaimed water into a water treatment plant (EPA, 2012).   
Augmentation of drinking water sources through reclamation by land application to recharge 
subsurface aquifers can be achieved through surface spreading for infiltration and injection 
wells. Surface spreading refers to the percolation of water back into the aquifer (Water Reuse, 
2012). Direct injection involves pumping recharge water directly into a confined or unconfined 




direct injection is effective in creating barriers against saltwater intrusion, further protecting 
the areas freshwater supply (Asano et al., 2007).  
History of Water Reuse in the United States 
California has been advancing the use of water reclamation as early as the 1890s. Early water 
reuse projects focused mostly on non-potable reuse for urban settings. In particular, Golden 
Gate Park in San Francisco, CA began using reclaimed water to maintain ornamental lakes and 
to irrigate the landscape in 1912 (Asano et al., 2007). The first operational water reclamation 
plant in the United States opened in 1926 in Grand Canyon Village, Arizona and remained 
operational until a replacement facility opened in 1989 (Asano et al., 2007). The purpose of this 
facility was to provide a non-potable source of water to a heavily touristed location.  
Indirect potable reuse has been implemented for use within the United States since the early 
1960’s (Asano et al., 2007). One of the first projects to become operational was the Los Angeles 
County Sanitation Districts’ Montebello Forebay Project (EPA, 2017). The first groundwater 
recharge via direct injection appeared in 1985 in El Paso, Texas. Currently, there are at least 25 
operational or planned IPR and DPR projects in the United States, including the proposed IPR 
facility assessed in this study (EPA, 2017).   
Human Enteric Viruses 
A public health concern for water reuse is that wastewater has high concentrations of various 
pathogenic microorganisms, including bacteria, viruses, protozoa, and helminths. These 
pathogenic microorganisms are known to cause gastrointestinal and systemic illnesses in 




pathogen is excreted in feces of humans and then consumed by ingestion that may lead to an 
infection and illness.  
The removal and inactivation of pathogens in water has gained importance as the number of 
sensitive subpopulations has increased, now thought to comprise 20-25% of the total U.S 
population (C P Gerba, Rose, & Haas, 1996). These sensitive subpopulations include the elderly, 
the very young, the immunocompromised, and pregnant women. Studies show that, when 
compared to the general public, these sensitive subpopulations are more likely to be infected 
and experience increased morbidity and mortality following exposure to a microbial pathogen 
(C P Gerba et al., 1996; Nwachuku & Gerba, 2006).  
In particular, human enteric viruses are of special interest due to their ability to cause infection 
in humans in low doses and their excretion in the feces in large quantities. Viruses are also not 
efficiently removed by conventional filtration treatment processes due to their small size, they 
are more resistant to disinfection when compared to bacteria, and they can persist and travel 
further in the environment, especially in groundwater sources (Sano, Amarasiri, Hata, 
Watanabe, & Katayama, 2016). A study of US drinking water outbreaks from 1971 to 2006 
identified viruses as the etiologic agent in approximately 8% of the outbreaks (Craun et al., 
2010). 
Human adenoviruses have been found to have long-term survival and persistence in 
environmental waters (Rigotto et al., 2011). These viruses are the second-leading cause of 
gastroenteric disease in children worldwide, and are a major cause of clinical infections 




Van Zyl, & Grabow, 2003). Adenoviruses are resistant to chemical disinfection by chlorination 
and UV light inactivation of water (Thurston-Enriquez, Haas, Jacangelo, Riley, & Gerba, 2003). 
Many studies have recognized the importance of water in the epidemiology of human 
adenoviruses and the potential health risks associated with these viruses in water 
environments (Enriquez, 1995; Mena & Gerba, 2009; Puig et al., 1994; Van Heerden et al., 
2003). 
Enteroviruses are among the most common and significant causes of infectious illness in infants 
and children. Nwachuku and Gerba (2006) suggest that children are more vulnerable and are at 
a greater risk of infections from serious enteric, respiratory and systemic enteroviral illnesses 
than adults. Numerous studies have documented the presence of enteroviruses in the 
environment, including groundwater, raw water, and treated water (Abbaszadegan, Stewart, & 
LeChevallier, 1999; Bosch, Guix, Sano, & Pintó, 2008; Keswick, Gerba, DuPont, & Rose, 1984; 
Vivier, Ehlers, & Grabow, 2004).  
Reoviruses are capable of infecting the human respiratory and intestinal tracts, resulting in 
asymptomatic or mild respiratory infections (Dermody, Parker, & Sherry, 2013). These viruses 
have a high endemic infection rate in humans and mammals (Dahling, Safferman, & Wright, 
1989; Ridinger, Spendlove, Barnett, George, & Roth, 1982). Studies have found frequent 
occurrence of reovirus in raw sewage and treated wastewater effluent in both the US and the 
Netherlands (Askew, Bott, Leach, & England, 1965; Betancourt & Gerba, 2016; Dahling et al., 
1989; England, 1972; Lodder & de Roda Husman, 2005; Sedmak, Bina, Macdonald, & Couillard, 
2005). Additional studies have found reovirus to be environmentally stable outside of its host, 




26°C and longer than 1 year in 8°C (Berard & Coombs, 2009; McDaniels, Cochran, Gannon, & 
Williams, 1983). Furthermore, studies assessing reovirus in the subsurface have found the virus 
to be the most common enteric virus in groundwater and have also found evidence at managed 
aquifer sites to suggest that they may travel further than other enteric viruses in the subsurface 
(Betancourt et al., 2014). Reoviruses also appear to be more sensitive to chlorine disinfection 
than other enterovirus, but are more resistant to UV disinfection (Chevrefils et al., 2006; Drulak, 
Wallbank, & Lebtag, 1984; Liu, Seraichekas, Akin, DA Brashear, & Katz, 1971; Lytle & Sagripanti, 
2005).  
Current Water Reuse Guidelines for Indirect Potable Reuse 
Currently, there are no federal regulations to address potable reuse in the US (EPA, 2017). The 
two U.S federal statutes that could have an impact on these recommendations are the Clean 
Water Act (CWA) and the Safe Drinking Water Act (SDWA). The CWA was passed in the early 
1970s in response to the growing concerns for the discharge of untreated wastewater from 
municipalities, industries, and businesses into rivers, lakes, and coastal waters. The standards 
set by the CWA determine the type of wastewater treatment required to meet set effluent 
standards for microbial, chemical and other contaminants. Shortly after the passage of the 
CWA, the SDWA was passed to set the minimum quality of standards required for public 
drinking water supply systems. Both of these federal statutes provide the core regulatory 
requirements needed to develop regulations regarding potable water reuse. Regulations for 





California is currently faced with an unprecedented risk to its water supply. To address this 
issue, California has developed state regulations regarding the microbial quality of treated 
wastewater intended for IPR. Of interest to this project, California has set a 12-log10 reduction 
target of viruses for when treated wastewater is used for groundwater recharge intended for 
indirect potable reuse (Title 22 and 17 California Code of Regulations State Board, 2015). The 
regulation allows for an additional 1-log10 removal per month of subsurface residency time 
(minimum 2 months) to be credited to the 12-log10 reduction target for viruses. Other 
pathogens of interest to public health, including protozoans such as Giardia lamblia and 
Cryptosporidium spp., and bacteria such as Salmonella spp. and Campylobacter spp., require a 
10-log10 reduction when treated wastewater is intended for IPR.   
Given that the issue of an increasing urban population and improper water resource 
management is not unique to California, other states across the United States have begun 
developing their own regulations regarding IPR and DPR. The State of Texas has developed a 
similar plan for DPR as California’s requiring a 12/10/10-log10 reduction for viruses, Giardia 
lamblia and Cryptosporidium spp., respectively (Texas, 2015).The State of North Carolina has 
also enacted legislation to allow for the development of blended water reclamation systems for 
both IPR and DPR, known as NC “Type 2” reclaimed water (North Carolina General Assembly, 
2014). Under this statute, the state requires a dual disinfection system comprising UV 
disinfection and chlorination (or an equivalent dual disinfection system) to achieve a 6-log10 
reduction of Escherichia coli, 5-log10 reduction of coliphages, and 4-log10 reduction of 
Clostridium perfringens as indicators for pathogenic bacteria, viruses and protozoan parasites.  




Traditionally, the detection and quantification of human enteric viruses from water samples 
relied on cell culture infectivity techniques. An issue that arises from the use of traditional cell 
culture techniques are that they rely on the identification of positive cytopathic effect (CPE). 
However, many viral pathogens of concern do not grow in any known cells cultures or they 
grow but produce no visible CPE. Therefore detection methods are limited by the ability of 
viruses to grow on a cell line (Reynolds, 2004). This is an issue as there is documentation that 
not all viruses are capable of producing CPE even during an infectious event (Reynolds, Gerba, 
Abbaszadegan, & Pepper, 2001; Reynolds, 2004).  
A more sensitive and specific approach to detecting viruses in water samples is through the use 
of polymerase chain reaction assays, such as qPCR (real-time PCR), RT-PCR (reverse 
transcription PCR), and RT-qPCR (reverse transcription real-time PCR). An advantage of PCR is 
that the method can detect viruses that are nonculturable on cell lines, or do not produce visual 
signs of CPE (Reynolds, 2004). The detection of viruses through PCR can depend on the 
presence of inhibitors, efficiency of virus recovery, and the purity of the recovered nucleic acid 
(Fong & Lipp, 2005). Detection of viruses based on PCR-only assays leads to an issue of 
detecting all targeted genes within a sample whether the viruses or their nucleic acids are 
infectious or not (Abbaszadegan et al., 1999; Gantzer, Maul, Levi, & Schwartzbrod, 1998). The 
assay cannot discriminate between target genes that were produced during infection, 
replicating viruses, and gene fragments present within the sample that may have originated 
from inactivated viruses (Abbaszadegan et al., 1999; Sobsey, Battigelli, Shin, & Newland, 1998).  
Incorporating cell culture with molecular methods, such as ICC-RT-qPCR, has allowed for better 




the advantages of both cell culture and PCR assays. These advantages include the increased 
sensitivity and specificity and detection of infectious viruses. A benefit gained from adding a 
PCR assay to a cell culture assay is the ability to detect viruses that may be present and 
infectious, but may take longer to display signs of CPE, or may not display them at all (Rodríguez 
et al., 2009). A disadvantage to ICC-RT-PCR is that, since it is based on cell culture, the detection 
of viruses is limited to those that are culturable on cell lines (de Roda Husman, Lodder, Rutjes, 
Schijven, & Teunis, 2009). Overall, ICC-PCR or ICC-RT-PCR has become the method now 
considered the most effective to detect and quantify human enteric viruses of health concern.  
Therefore, this is the method that will be used in this study to detect and quantify human 
adenoviruses, enteroviruses and reoviruses. 
METHODS 
 
Candidate Viruses and Cell Lines 
 
The viruses potentially culturable in the infectivity assay experiments in this report were human 
enteroviruses (capable of infecting Buffalo Green Monkey cells), reoviruses (capable of infecting 
Buffalo Green Monkey cells), and enteric adenoviruses (capable of infecting modified G293 
cells). The positive control viruses used were Echovirus 12 for enteroviruses, adenovirus type 2 
for adenoviruses, and reovirus type 3 Dearing strain for reoviruses.  
BGM Cell Line Maintenance 
 
The BGM continuous cell line was passaged serially as described previously (Fout et al., 2014; 




0.05% trypsin with ethylenediaminetetraacetic acid (EDTA) was added directly onto the cell 
monolayer per 150 cm2 cell culture flask. The flask was incubated at 37°C (± 1°C) for 3 minutes 
to enhance detachment of BGM cells from the culture vessel. The cell suspension was added to 
a centrifuge tube with an equal volume of BGM growth medium (consisting of a 50/50 mixture 
of Eagle’s modified minimum essential medium (EMMEM) and Leibovitz-15 medium with L-
glutamine, 1 ml/L of 7.5% sodium bicarbonate, 10mL/L of penicillin-streptomycin (10,000  
units/mL-10,000 µg/mL, respectively) and fungizone (250 µg/mL of amphotericin B and 205 
µg/mL of sodium deoxycholate) concentrated stocks, and 100 mL/L of heat inactivated fetal 
bovine serum) to neutralize the effect of trypsin on the cells. The cells were pelleted by 
centrifugation of the cell suspension at 2,000 RPM for 10 minutes and the cell pellet was 
resuspended in 5-10 mL of BGM growth medium. A sample of 100 µL of the resuspended cell 
suspension was mixed with 200 µL of 0.04% trypan blue solution to determine the live cell 
count by microscopic analysis in a hemocytometer under 100X magnification. 
Cell culture assay dishes for the BGM cell line were created in 24-well tissue culture plates. The 
live cell count was used to create a suspension of cells in BGM growth medium to contain a 
concentration of 105 cells/mL. Approximately 1 mL of this cell suspension was dispersed into 
each well of the 24-well tissue culture plate. The tissue culture plates were incubated at 37°C (± 
1°C) for 3-7 days until 80-90% cell confluency was reached.  
G293 Cell Line Maintenance 
 
The G293 cell line was maintained in a similar method as the BGM cell line, and based on work 




basis, spent medium was removed from the cell culture flask and 30 mL of phosphate buffered 
saline (PBS) was added per 150 cm2 cell flask. The G293 cell monolayer was detached by using 
repeated pressure from the action of filling and emptying a pipette to create a flow of PBS 
against the cell monolayer. The cell suspension was then centrifuged at 2,000 RPM for 10 
minutes to pellet the cells. The resulting supernatant was discarded and the cell pellet was 
resuspended in 5-10 mL of G293 growth medium consisting of 800 mL/L of minimum essential 
medium (MEM), 12 mL/L of 7.5% sodium bicarbonate, 10 mL/L of 100X MEM non-essential 
amino acids (750 mg/L glycine, 590 mg/L L-alanine, 1.32 g/L L-Asparagine, 1.33 g/L L-aspartic 
acid, 1.47 g/L L-glutamic acid, 1.15 g/L L-proline, 1.05 g/L L-serine), 10 mL of 100mM sodium 
pyruvate, 10 mL/L of  gentamycin-kanamycin antibiotic solution (5 g/L gentamicin sulfate, 25 
g/L kanamycin monosulfate), 10 mL/L of nystatin (750mg/L), 10 mL/L of 100X HEPES buffer (356 
g/L HEPES, 15 g/L sodium hydroxide), 38 mL/L of distilled, autoclaved water, and 100 mL/L of 
heat inactivated fetal bovine serum. A sample of 100 µL of the resuspended cell pellet was 
analyzed under a hemocytometer as for the BGM cells to obtain a cell count and compute the 
cell concentration.  
Cell culture dishes (24-well) for experimental analysis were prepared 3-5 days before the 
infectivity assay experiments to allow for the cell monolayer to reach 80-90% confluency. The 
cell culture dishes were prepared by determining the amount of cell suspension required for a 
cell concentration of 105 cells/mL. Following this, 1 mL of the adjusted cell suspension was 
added into each well and the cell culture dish was placed in an incubator at 37°C (± 1°C) until 




Propagation of Stock Viruses 
 
All viruses were propagated in a similar way as described in (Rodríguez et al., 2013). For 
propagation of stock type 2 adenovirus, 100 µL of stock adenovirus concentration was diluted 
with 900 µL of minimum essential media (MEM). A 150 cm2 cell culture flask with a confluent 
G293 cell monolayer was decanted of spent media, and the virus inoculum was added to the 
flask. 50 mL of maintenance media (consisting of 800 mL/L of minimum essential medium 
(MEM), 12 mL/L of 7.5% sodium bicarbonate, 10 mL/L of 100X MEM non-essential amino acids 
(750 mg/L glycine, 590 mg/L L-alanine, 1.32 g/L L-Asparagine, 1.33 g/L L-aspartic acid, 1.47 g/L 
L-glutamic acid, 1.15 g/L L-proline, 1.05 g/L L-serine), 10 mL of 100mM sodium pyruvate, 10 
mL/L of  gentamycin-kanamycin antibiotic solution (5 g/L gentamicin sulfate, 25 g/L kanamycin 
monosulfate), 10 mL/L of nystatin (750mg/L), 10 mL/L of 100X HEPES buffer (356 g/L HEPES, 15 
g/L sodium hydroxide), 38 mL/L of distilled, autoclaved water, and 10 mL/L of heat inactivated 
fetal bovine serum) was added to the flask and the flask was incubated at 37°C (± 1°C) until 
signs of cytopathic effect (CPE) were observed uniformly throughout the flask. A cell scrapper 
was used to collect the cell monolayer and spent medium in a 250 mL polypropylene centrifuge 
tube. The collected cells underwent 3 freeze-thaw cycles at -70°C (± 1°C) to disrupt and lyse the 
cells. Lysed cells were removed by centrifugation at 3500 x g for 30 minutes at 4°C.  The 
resultant supernatant was kept as virus stock and stored at -70°C (± 1°C) until use.  
Propagation of stock echovirus 12 and reovirus type 3 Dearing strain were performed in a 
similar method described above and similarly described by (Gallagher & Margolin, 2007). Stock 




and added to a drained 150 cm2 tissue culture flask with a confluent BGM cell monolayer. 50 
mL of BGM maintenance medium (consisting of a 50/50 mixture of Eagle’s modified minimum 
essential medium (EMMEM) and Leibovitz-15 medium with L-glutamine, 1 ml/L of 7.5% sodium 
bicarbonate, 10mL/L of penicillin-streptomycin (10,000  units/mL-10,000 µg/mL, respectively) 
and fungizone (250 µg/mL of amphotericin B and 205 µg/mL of sodium deoxycholate) 
concentrated stocks, and 10 mL/L of heat inactivated fetal bovine serum) was added to the 
tissue culture flask and was subsequently incubated at 37°C (± 1°C) until signs of CPE were 
observed uniformly throughout the flask. The monolayer was dislodged with vigorous pipetting 
and collected in a 250 mL polypropylene centrifuge tube and underwent 3 freeze-thaw cycles at 
-70°C (± 1°C) and 25°C (± 1°C) to induce cell lysis. The lysed cells lysed cells were removed by 
centrifugation at 3500 x g for 30 minutes at 4°C. All viruses were recovered from the 
supernatant and stored at -70°C (± 1°C) until use.  
Sample Collection and Preparation 
 
Samples were received from the Hampton Roads Sanitation District (HRSD) via FedEx Priority 
Overnight shipping and stored at 4°C (±1°C) for 1-24 hours until use. Samples received from the 
sanitation district underwent filtration through a 25S Rexeed Ultrafilter. Secondary 
concentration through polyethylene glycol precipitation (6% PEG, 0.3 M NaCl, pH 7.0) was 
performed with methods previously used by the lab (Rodríguez et al., 2013).  PEG precipitation 
was performed on the filtered eluate with overnight incubation on an orbital shaker at 4°C and 
2,200 RPM. A virus pellet was collected by centrifugation at 4,200 RPM for 60 minutes and was 




clarified, and final wastewater effluent samples; 60 mL for SWIFT reclaimed water sample). Raw 
sewage, secondary clarified, and final wastewater effluent samples were collected from a 
wastewater treatment plant in Nansemond, Virginia. The SWIFT polit reclaimed wastewater 
sample was collected from the pilot site in Seaford, Virginia. 
Raw sewage, secondary clarified, and final effluent samples were concentrated from an initial 
starting volume of 2 L to an ending volume of 30 mL. Final “SWIFT” reclaimed water samples 
were concentrated from a starting volume of 100 L to a final volume of 60 mL.  
A series of 10-fold serial dilutions were created in 1.5 mL microfuge tubes. Dilutions used to 
infect the BGM cell line were made in Eagle’s modified minimum essential medium (EMMEM). 
The dilutions used to infect the G293 cell line were made separately in minimum essential 
medium (MEM).  
Wastewater and Reclaimed Water Treatment Plant Configuration and Samples for Virus 
Testing 
 
The main purpose of the study is to determine and compare the concentration of culturable 
enteric viruses detected in the “SWIFT” reclaimed water with the concentration of culturable 
enteric viruses detected in the final effluent samples of a wastewater treatment facility. Figure 
2 displays the configuration of the two separate wastewater reclamation and treatment trains 
from which separate samples were obtained and assayed for culturable human enteric viruses. 
Each sampling point assessed in this study is represented by a blue pentagon.  
The tested raw sewage was collected prior to any primary treatment. Secondary clarified 




secondary treatment (5-stage Bardenpho). The wastewater treatment plant effluent, from now 
on referenced as “final effluent”, underwent disinfection through chlorination (free chlorine, 
average dose = 2.12 mg/L). 
The final reclaimed water effluent sample, hereafter designated “SWIFT”, was collected from a 
separate wastewater treatment train described above. The SWIFT sample underwent similar 
primary treatment conditions. For secondary treatment, the sample also underwent a similar 
treatment process. The reclaimed water stages of the treatment train begin after secondary 
treatment with water being diverted from the wastewater treatment train to the reclaimed 
water treatment train. Briefly, the pilot SWIFT treatment train included coagulation and 
flocculation (aluminum chloralhydrate as coagulant and ferric chloride as flocculant), 
sedimentation, biologically active carbon filtration, denitrification, granular activated carbon 
contact, and lastly, UV disinfection (186 mJ/cm2). The SWIFT sample analyzed was collected as 
the effluent of this treatment train, with the addition of dissolved solids (up to 500 ppm) to best 




Figure 2.  Schematic overview of the wastewater treatment and pilot reclaimed wastewater treatment facility assessed in this report. Blue 
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Cell Culture Cytotoxicity Experiments 
 
Raw sewage, secondary clarified, and final effluent samples received from Hampton Roads 
Sanitation District were initially assessed for their cytotoxicity to the cell line. When water 
samples are further concentrated from a high volume, substances that might be toxic to the cell 
lines or viruses can also be concentrated. These preliminary experiments were conducted to 
examine if substances that are toxic to or can inhibit the growth of G293 and BGM cell lines and 
their respective viruses are found in the concentrated water samples received from the 
sanitation district. If toxic effects are found to be present in the undiluted concentrated 
samples, then it would be important to determine the dilution at which this effect is no longer 
present. 
Samples were pasteurized for 10 hours at 65°C (±1°C) in a water bath to inactivate nearly all 
microorganisms. 50 µL of adenovirus type 2, echovirus 12, and reovirus type 3 were spiked into 
1 mL aliquots of each sample dilution for a series of 10-fold virus dilutions. Raw sewage samples 
were tested for cytotoxicity at undiluted, 10-fold, 100-fold, and 1000-fold dilutions. Secondary 
clarified were tested at undiluted, 10-fold, 100-fold, and 300-fold dilutions. Final effluent 
samples were assessed for cytotoxicity at undiluted, 10-fold, 30-fold, and 100-fold dilutions. 
Volumes of 100 µL of each virus-spiked test sample dilution were inoculated onto confluent 
layers of G293 and BGM 24-well cell culture trays in sets 4 of dilutions with 6 replicates per 
dilution. The G293 cell culture trays were examined for signs of CPE after 2 days and were 
harvested 5 days post inoculations. The BGM cell culture trays were examined for signs of CPE 




performed for both harvested BGM and G293 cells, followed by reverse transcription and then 
PCR for adenovirus mRNA in G293 cells, and enterovirus and reovirus mRNA in BGM cells.  
Inoculation of test samples on the BGM cell line 
 
The BGM cell line was inoculated using an adapted version of Fout et al. (2014). Cell wells (24-
well cell culture wells) were infected once 80% confluency had been reached. Spent media was 
removed from the wells by aspiration and the monolayer was subsequently carefully washed 
with Hanks Balanced Salt Solution (HBSS). Cell monolayer wells were inoculated with 140 µL of 
the test sample and were then incubated at 25°C (± 1°C) for 90 minutes on a rocking platform 
set at 1-5 oscillations/min to allow for the viruses to adsorb onto and infect cells. Positive 
control plates were infected with 100 µL of reovirus type 3 Dearing strain and echovirus type 
12, while negative controls were infected with 140 µL of EMMEM. Following incubation, the 
inoculum was removed from the wells and replaced with 1 mL of maintenance medium and the 
cell culture dishes were incubated at 37°C (±1°C).  
After 5-7 days, the BGM cell line was checked for signs of cytopathic effect (CPE) under a 
microscope at 100X magnification. Fresh BGM maintenance medium was refed to the cells 
every 7 days, with the spent medium being removed by aspiration.  Once 14 days had passed 
from the initial inoculation, the cell monolayer was disrupted by pipetting its contents up and 
down vigorously and collecting in a 1.5 mL microfuge tube. The samples were subsequently 
frozen at -80°C (± 1°C) for analysis after a second passage. 
A second batch of 24-well cell trays were prepared and inoculated with the thawed medium 




descried above. Visual checks for CPE development were conducted every 3 days, with a total 
additional incubation period of 7-10 days. The cell monolayer was disrupted by vigorous 
repeated pipetting and collected in a sterile 1.5 mL microcentrifuge tube. This was next 
centrifuged in a mini-centrifuge at 2,000 RPM for 5 minutes to form a cell pellet. The 
supernatant of each microfuge tube was discarded and all cell pellets were stored at -80°C (± 
1°C) until RT-qPCR analysis. Virus titers in the cell pellet were expected to be at least as high as 
those in the cell culture supernatant  
Inoculation of test samples on the G293 Cell Line 
 
The G293 cell line was inoculated with samples for virus assay and processed using the 
previously developed protocol (Rodríguez et al., 2013). Cell culture dishes (24-well) were 
prepared at 80% confluency of the monolayer and spent medium was removed. The G293 
monolayer was next carefully washed with PBS. Wells were inoculated with 140 µL of test 
sample and the cell culture dishes were incubated at 37°C (± 1°C) for 60 minutes, with manual 
agitation in 15-minute intervals. Positive control plates were inoculated with 100 µL of serial 
10-fold dilutions of adenovirus type 2, and negative control plates were inoculated with 140 µL 
of MEM. Following incubation for 60 minutes, the sample inoculum was removed and 1 mL of 
G293 maintenance medium was added to each well.  
After 3-5 days of incubation, cell culture trays were checked for signs of CPE. The cell 
monolayer was collected by removing the spent medium and adding 1 mL of MEM to dislodge 
the monolayer by continuously pipetting the solution up and down. The cell monolayer was 




minutes to form a cell pellet. The resulting supernatant was discarded and the cell pellet was 
stored at -80°C (± 1°C). No second passage was performed on the samples inoculated on G293 
cell line. 
Quantification of results 
 
Cell culture results were quantified through brightfield microscopic observation of cytopathic 
effect under 100X magnification. Characteristics of adenovirus CPE include the swelling and 
aggregation of cells into grape-like clusters (Lu, Joshi, & Flomenberg, 2014). The infected G293 
cell line was monitored for signs of CPE 3 days after inoculation, and was scored as “positive” 
for CPE if approximately 75% of the cell monolayer was displaying characteristic signs of CPE.  
The BGM cell line was assessed for signs of CPE 3-5 days after the initial infection. 
Characteristics of reovirus CPE include the formation of clumped granular cells. Signs of the 
enterovirus CPE were similar to those of reovirus. The visual identification for enterovirus CPE 
was destruction of the cell monolayer, resulting in shrinkage and pyknosis of the cells (Suchman 
& Blai, 2007). Due to the similarity in CPE characteristics, it was difficult to distinguish between 
reovirus-only CPE and enterovirus-only CPE. Positive CPE samples were labeled as such if the 
respective monolayer displayed signs of at least 75% percent CPE for both first and second 
passages. 
Once CPE positive and negative CPE scores had been obtained, a most probable number (MPN) 
estimate was used to quantify the concentration of viruses present in the samples. The MPN 




used to report estimated MPN values was the Food and Drug Administration’s (FDA) 
Bacteriological Analytica Manual (BAM) MPN calculator (FDA, 2010). 
Nucleic Acid Extraction 
 
 The previously collected cell pellets were thawed and lysed with 250 µL of RLT lysis buffer 
(composed of 100 mL of TE buffer, 120 g guanidine thiocyanate, 11 mL of 5M sodium chloride, 
11 mL of 3M sodium acetate [pH = 5.5], 2.2 mL of polyadenylic acid potassium salt (2.3 µM/mg 
poly(A)) supplemented with 1% mercaptoethanol. This mixture was next homogenized with 
QIAshredder (Qiagen, USA) and centrifuged at full speed (15,000 RPM) for 2 minutes before 
transferring the liquid into a new 1.5 mL microcentrifuge tube and repeating this procedure 
twice. A volume of 250 µL of 100% (200-proof) molecular grade ethanol was added to the 
homogenized cell mixture and was subsequently vortexed for one minute and then incubated 
at room temperature for 5 minutes.  
The resultant mixture was added to an Omega Biotek HiBind® RNA V-Spin column and 
centrifuged at full speed (15,000 RPM) for 2 minutes. The original collection tube was discarded 
while the column was placed on top of a clean collection tube. The column was next flushed 
with 500 µL of 75% molecular grade ethanol and vortexed at full speed for 2 minutes. The 
collection tube was discarded and the column was placed on top of a clean collection tube. This 
process was repeated before centrifuging the column at full speed again for 2 minutes to spin 
out any remaining wash liquid.  
The next steps of nucleic acid extraction were the placement of the column in a clean collection 




temperature for 5 minutes. This column was then centrifuged at full speed (15,000 RPM) for 5 
minutes and the resultant effluent is the purified, extracted nucleic acid.  
DNase Treatment of Extracted Nucleic Acid 
 
For one reaction, a DNase treatment master mix was prepared with the following volumes: 2 µL 
of RQ-1 RNase-free DNase (Promega, USA), 2 µL of 10xPCR reaction buffer, and 0.5 µL of RNase 
inhibitor (40units/µL) for a total DNase treatment master mix volume of 4.5 µL. This master mix 
was next added to 15 µL of extracted nucleic acid and incubated at 37°C for 30 minutes before 
adding in 2 µL of RNase stop treatment. This mixture was next incubated at 65°C for 10 minutes 
and then immediately chilled on ice for 10 minutes.  
Reverse Transcription of DNase Treated Extracted Nucleic Acid 
 
A reverse transcription master mix 1 (RTMM1) was prepared containing the following volumes, 
for one reaction: 1.25 µL of dT15 primers (50 µM) and 2.5 µL of dNTPs (10 µM each) for a total 
volume of 3.75 µL of RTMM1. This RTMM1 mixture was added to 13.5µL of DNase treated 
nucleic acid and incubated at 65°C for 3 minutes, followed by an ice chill for at least 10 minutes 
or longer until ready for next step. 
Then, a reverse transcription master mix 2 (RTMM2) was prepared with the following volumes 
for one reaction: 2 µL of DTT (100 mM), 5 µL of 5X RT buffer, 0.25 µL of RNase inhibitor (40 
units/µL) and 0.30 µL of RT Enzyme SuperScript™ II for a total volume of 7.55 µL. The RTMM2 
was added to the reaction tube with RTMM1 and DNase treated nucleic acid on ice. The 




65°C for 15 minutes, and 4°C for 10 minutes. The resulting cDNA can be stored at 4°C for short 
term use (within 72 hours) or placed in -20° C for long term storage. 
Real-Time PCR (qPCR) of cDNA 
 
qPCR was performed using a Bio-Rad CFX96 Touch™ System under the following cycle 
conditions: 95°C for 15 minutes for denaturing; followed by 45 cycles of 94°C for 15 seconds, 
60°C for 60 seconds; and held at 4°C. The PCR master mix (PCRMM) was prepared with 4.75 µL 
of molecular grade water, 12.5 µL of 2X QuantiTect Probe, 2.25 µL of forward primer (10 µM), 
2.25 of reverse primer (10 µM), and 1.25 µL of the TaqMan® probe (5 µM), for a total volume of 
23 µL per reaction. In addition to the PCRMM, 2 µL of the collected cDNA from each respective 
cell line was used in the qPCR assay. The assay and primers used in this study were based on 
PCR assays previously developed (Fout et al., 2014; Jothikumar et al., 2005; Kostiuk, 2015; Leon 
& D., 1990; Monpoeho et al., 2000; Osuolale & Okoh, 2015; Qiu et al., 2015). Table 1 displays 
the primers and probes for adenovirus, reovirus, and enterovirus. 
Table 1. PCR primers and TaqMan® probes used in this report for adenovirus, reovirus, and 
enterovirus. Abbreviations: 5-carboxyfluorescein (FAM, reporter dye); black hole quencher (BHQ, 




5’-GGACGCCTCGGAGTACCTGAG-3’ (Jothikumar et al., 2005; Osuolale 











5’-AGTTGCTGAACGCAAATTATTTTG-3’ (Qiu et al., 2015) 







5’-CCTCCGGCCCCTGAATG-3’ (Fout et al., 2014; Leon & D., 
1990; Monpoeho et al., 2000) 







Statistical Analysis of Results 
Statistical tests were conducted using R version 3.5.3 and RStudio version 1.0.153 as the 
integrated development environment (IDE). All statistical tests employed a significance level of 
0.05. A major assumption used in all tests was that the data was not normally distributed, and 
thus non-parametric statistical tests were employed. Percent positive values for infectious 
viruses of each type analyzed were reported by calculating the number of samples testing 
positive for these viruses detected through the MPN estimate by ICC-RT-qPCR over the total 
number of samples assessed. Fisher’s exact test was used to determine any differences in the 
occurrence of positive detections at each water sampling point. To compare the median of 




rank sum test was used to determine significant differences between the medians of two 
samples.  
Log10 reduction values (LRVs) were calculated by subtracting the log10 concentration of viruses 
in the ending point of the treatment train (final effluent or SWIFT) from the log10 concentration 





Adenovirus was spiked into samples of raw sewage, secondary clarified, and final effluent, 
received from HRSD at dilutions described in the Methods section. A positive control made 
from stock adenovirus type 2 in MEM was used for comparison. The purpose of this experiment 
was to determine the presence of cytotoxic effects by the samples on the cell line integrity and 
virus infectivity.  
Observed concentrations of adenovirus in the positive control and water samples are displayed 





Figure 3. Detection of adenovirus type 2 infectivity (Log10 MPN/mL) in sample types (raw 
sewage, secondary clarified, and final effluent) at different sample dilutions (undiluted, 10-fold, 
30-fold, 100-fold, 300-fold, 1000-fold).  Experiments were conducted in 4 dilutions of 6 
replicates. Error bars represent 95% confidence intervals. 
 
A Kruskal-Wallis test was employed on the medians of each of the sample types to determine if 
there was a significant variance between the medians of the samples. The null hypothesis 
tested assumed that there would be no difference between the samples. With a p-value of 0.39 
at the confidence level of 0.05, The null hypothesis is not rejected. A Dunn correction was also 
performed on Kruskal-Wallis test results to add statistical robustness. These results further 
confirm that there was no difference between the medians of the samples. 
A Kruskal-Wallis test was also performed on the medians of the reovirus and enterovirus 
concentrations for the same sampling points and conditions described above for adenovirus. At 
the alpha level of 0.05, a p-value of 0.42 is obtained, and thus, the null hypothesis of no 
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also fails to yield any significant p-value corrections, indicating that there is no difference in the 
median virus concentration between the samples.  
 
Figure 4. Detection of enterovirus and reovirus (Log10 MPN/mL) based on CPE counts only in 
spiked samples of raw sewage, secondary clarified, and final effluent at sample dilutions of 
undiluted, 10-fold, 30-fold, 100-fold, 300-fold, 1000-fold to evaluate cytotoxicity effects. 
Experiments were conducted in 4 dilutions of 6 replicates. Error bars represent 95% confidence 
intervals 
The Kruskal-Wallis test results of p = 0.39 and p = 0.42 indicate that there is no difference in the 
medians between the samples when compared to the positive control. Based on these results 
there is no evidence of detectable cell culture cytotoxicity within the samples received from the 
sanitation district that could damage the cell line and their ability to support the infectivity of 
the target viruses. These results allowed for the use of undiluted samples in assessing the 
presence and concentration of enteric viruses in future samples.  
Prevalence of Enteric Viruses in Water and Wastewater Samples 
 
The purpose of these experiments was to detect and quantify the presence of infectious 

























reclaimed water of this study. Raw sewage, secondary clarified wastewater, wastewater final 
effluent, and SWIFT water samples were each inoculated onto confluent cell culture layers in 24 
well cell trays in sets of 6 replicates per 4 10-fold sample dilutions. A most probable number 
estimate was used to quantify the concentration of viruses present within each sample based 
on a combination of the results from CPE and RT-qPCR. 
Table 2 summarizes the detection of adenovirus, reovirus, and enterovirus in raw sewage 
samples for five monthly sampling events. Adenovirus was the most commonly found enteric 
virus, being present in 100% of the raw sewage samples. The second most detected enteric 
virus in raw sewage was reovirus with 60% of samples being positive. Enterovirus was not 
detected in any of the 5 raw sewage samples.  
Table 2. Prevalence of adenovirus, reovirus, and enterovirus in raw sewage samples from one 
wastewater treatment plant over 5 months. Experiments were conducted in 4 dilutions of 6 
replicates 
Sample Type Month Year Adenovirus Reovirus  Enterovirus 
Raw sewage  October 2017 + + - 
 
November 2017 + - - 
 
December 2017 + + - 
 
January 2018 + - - 
 
February 2018 + + - 
Total positive/total number samples (% positive samples) 5/5 (100%) 3/5 (60%) 0/5 (0%) 
 
In the secondary clarified wastewater samples from the wastewater treatment plant, the 




enterovirus (0%), as summarized in table 3. Enterovirus was not detected in any of the 
secondary clarified samples.  
Table 3. Prevalence of adenovirus, reovirus, and enterovirus in secondary clarified effluent from 
one wastewater treatment over 5 months. Experiments were conducted in 4 dilutions of 6 
replicates 
Sample Type Month Year Adenovirus Reovirus  Enterovirus 
Secondary Clarified October 2017 + - - 
 
November 2017 + + - 
 
December 2017 + + - 
 
January 2018 + - - 
 
February 2018 + + - 
Total positive/total number samples (% samples) 5/5 (100%) 3/5 (60%) 0/5 (0%) 
 
The prevalence of infectious adenovirus, reovirus, and enterovirus in 5 monthly samples of final 
wastewater treatment plant effluent samples is summarized in table 4. Adenovirus was the 
most prevalent enteric virus in final effluent samples with 60% of samples testing positive. 
Reovirus was the next most frequently detected enteric virus as 2 out of 5 (40%) final effluent 
samples tested positive. Enterovirus was not detected in any of the final effluent water 
samples. 
Table 4. Prevalence of adenovirus, reovirus, and enterovirus in 5 monthly final effluent samples 
from one wastewater treatment. Experiments were conducted in 4 dilutions of 6 replicates. 
Sample Type Month Year Adenovirus Reovirus  Enterovirus 





November 2017 + - - 
 
December 2017 + + - 
 
January 2018 - - - 
 
February 2018 - + - 
Total positive/total number samples (% samples) 3/5 (60%) 2/5 (40%) 0/5 (0%) 
 
The prevalence adenovirus, reovirus, and enterovirus in 5 monthly reclaimed water samples 
from the SWIFT pilot treatment facility is shown in table 5.  Reovirus was detected most 
frequently in SWIFT samples, being detected in 3 out of 5 samples. Adenovirus was also 
detected in 2 out 5 samples SWIFT samples, while enterovirus was not detected in any of the 5 
SWIFT samples.  
Table 5. Prevalence of infectious adenovirus, reovirus, and enterovirus in 5 monthly final 
effluent (reclaimed water) samples taken from the SWIFT pilot wastewater reclamation facility. 
Experiments were conducted in 4 dilutions of 6 replicates  
Sample Type Month Year Adenovirus Reovirus  Enterovirus 
SWIFT  October 2017 - + - 
 
November 2017 + - - 
 
December 2017 + + - 
 
January 2018 - + - 
 
February 2018 - - - 





A Fisher’s exact test was performed on the frequency of positive and negative detection scores 
for the 3 different infectious enteric viruses 5 monthly raw sewage samples. The null hypothesis 
assumes that there is no statistical difference between the frequency of positive and negative 
detection scores between the enteric viruses in sewage. At the 0.05 alpha level, we obtain a p-
value less than 0.05, thus the null hypothesis is rejected. A further pairwise analysis allows 
determination of the virus groups for which the differences are statistically significant. From 
this analysis shown in table 6, it can be seen that the comparison between adenovirus and 
enterovirus is statistically significantly different.  
Table 6. Fisher’s exact test with pairwise post-hoc analysis on the frequency of positive and 
negative scores for infectious adenoviruses, reoviruses and enteroviruses in 5 monthly sewage 
samples. Asterisk (*) indicates a significant value at a 0.05 alpha level. n = 5 for each virus group 
Virus Pair Comparison Groups Fisher’s exact p-value Adjusted p-value 
All groups 0.00932* < 0.05 
Adenovirus - Reovirus  0.444 
Adenovirus - Enterovirus  0.024* 
Reovirus - Enterovirus  0.250 
 
Secondary clarified wastewater samples were also assessed for differences between the 
frequency of positive scores for the three different groups of enteric viruses detected in 5 
monthly samples. A Fisher’s exact test was used to test the null hypothesis of no difference 
between the frequency of positive scores of the samples. A significant result (less than 0.05) is 
obtained the alpha level of 0.05 and the null hypothesis of no significant differences in 




post-hoc analysis it was found that there was a significant difference in the frequency of virus 
detection between the adenovirus and enterovirus groups, as shown in table 7. 
Table 7. Fisher’s exact test with pairwise post-hoc correction on the frequency of positive and 
negative scores for secondary clarified samples. Asterisk (*) indicates a significant value at a 
0.05 alpha level. n = 5 for each virus group 
Secondary Clarified 
Comparison Group 
Fisher’s exact p-value Adjusted p-value 
All groups 0.00932* < 0.05 
Adenovirus - Reovirus  0.444 
Adenovirus - Enterovirus  0.024* 
Reovirus - Enterovirus  0.250 
 
Differences in the frequencies of positive detection of the three different enteric viruses in the 
5 monthly samples of final wastewater effluent also were compared using Fisher’s exact test. At 
the 0.05 alpha level of statistical significance, the reported p-value greater than 0.05 in table 8 
indicates that the null hypothesis of no difference in frequency of detection is not rejected.  A 
further post-hoc pairwise analysis for differences in frequency of detection of the three 
different viruses further strengthens the evidence of no significant difference, with all p values 
>0.05 (table 7).  
Table 8. Fisher’s exact test with pairwise post-hoc analysis on the frequency of positive and 
negative infectivity scores for three different enteric viruses in 5 monthly final effluent samples. 




Final Effluent Comparison 
Group 
Fisher’s exact p-value Adjusted p-value 
All groups 0.2507 > 0.05 
Adenovirus - Reovirus  1.00 
Adenovirus - Enterovirus  0.501 
Reovirus - Enterovirus  0.666 
 
SWIFT samples were also assessed for the frequency of positive infectivity detection scores for 
the three groups of enteric viruses in 5 monthly samples. Using a Fisher’s exact test at the 0.05 
alpha level of significance, it was found that the null hypothesis is not rejected (p-value = 
0.2507) for the frequency of detection of the three different viruses. A post hoc analysis of the 
frequencies of detection of the pairs of virus groups further strengthens the evidence of no 
significant differences, with all p vales >0.05, as shown in table 9.   
Table 9. Fisher’s exact test with pairwise post-hoc analysis on the frequency of positive and 
negative infectivity scores for adenovirus, reoviruses and enteroviruses in 5 monthly SWIFT 
samples of reclaimed water. n = 5 for each virus group 
SWIFT Comparison Group Fisher’s exact p-value Adjusted p-value 
All groups 0.2507 > 0.05 
Adenovirus – Reovirus  1.00 
Adenovirus - Enterovirus  0.66 





Concentrations of Infectious Adenoviruses, Reoviruses and Enteroviruses in Raw and 
Treated Wastewater and Reclaimed Water Samples 
 
The median log10 concentrations of the three groups of infectious human enteric viruses 
present in the wastewater and water samples analyzed is shown in figure 5. Two separate 
sample medians were calculated depending on the exclusion or inclusion of the virus non-
detect values that were obtained. The group labeled “Enteric Viruses Including Non-Detects” is 
the sample median infectious virus concentration across all 15 samples for that sample type. 
The “Enteric Viruses Excluding Non-Detects” group is the sample median infectious virus 
concentration when excluding non-detects.  
The median concentration of infectious human enteric viruses found in raw sewage was found 
to be 0.54 Log10 (MPN/100mL) when including values below the limit of detection, and 2.05 
Log10 (MPN/100mL) when excluding values below the limit of detection. For secondary clarified 
wastewater, the median concentration of infectious human enteric viruses was 0.59 Log10 
(MPN/100mL) when including non-detection values, and 1 Log10 (MPN/100mL) when excluding 
non-detection values. Concentrations of 0.52 Log10 (MPN/100mL) and 0.90 Log10 (MPN/100 mL) 
were reported for infectious human enteric viruses found in the final wastewater effluent when 
including values of non-detection, and when excluding values of non-detection, respectively. 
The median concentration of infectious human enteric viruses in SWIFT reclaimed water was 
found to be -1.16 Log10 (MPN/100mL) when including values of non-detect, and -0.57 Log10 




Sample medians including the limit of detection value (non-detects) tended to report lower 
concentrations of infectious viruses when compared to the median concentrations that 
excluded values at the lower limit of infectious virus detection (non-detects). To address the 
bias that may be caused by the presence of including values of non-detection when calculating 
the median concentration of all enteric viruses present within the sample, all statistical tests 
were conducted separately with both median groups. 
 
Figure 5. Median Log10 Concentrations of all Enteric Viruses (reovirus, enterovirus, and 
adenovirus) in sewage, secondary clarified wastewater, final wastewater effluent and SWIFT 
reclaimed water. Two medians are reported for each sample, one including values of virus non-
detect values, and the other excluding virus non-detect values. Error bars represent 95% 
confidence intervals; n = 15 for sample medians including values of non-detection; n > 8 for 
sample medians excluding values of non-detection. 
For comparison of the concentration of infectious viruses detected in each type sample, the 
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5). Treatment train 1 (TT1) is a conventional wastewater treatment train for which there are 
samples of the initial raw sewage, an intermediary secondary clarified wastewater, and the final 
treated wastewater effluent. Treatment train 2 (TT2) is a water reclamation pilot treatment 
train for which there are samples of initial raw sewage sample and the SWIFT water. 
A Kruskal-Wallis test was employed to compare the median sample concentration of all enteric 
viruses present within TT1. When including non-detect values in sample median 
concentrations, the p-value (p-value = 0.379) obtained from the Kruskal-Wallis test indicates 
that there is no significant difference between the median concentrations of all enteric viruses 
in TT1.  The Kruskal-Wallis test employed on the comparison of medians with excluding non-
detection value also indicates that there is no significant difference in the median 
concentrations of viruses between the samples (p-value = 0.352) for TT1. In summary, there is 
no significant difference in the concentrations of all infectious enteric viruses in TT1, even when 
controlling for the presence of non-detect values. 
To compare the median concentration of all infectious enteric viruses in TT2, a Wilcoxon rank 
sum test was employed. When values of non-detection in the calculation of sample medians of 
infectious virus concentrations, a significant p-value is reported (p-value = 7.04x10-6). This 
indicates that we reject the null hypothesis and have statistical evidence for a statistically 
significant difference in the concentrations of all infectious enteric viruses between different 
the two sampling points for TT2 (raw sewage and SWIFT). To control for the bias that may be 
introduced by the inclusion of non-detection values in the calculation, a second Wilcoxon-rank 
sum test was employed. When controlling for the effect of non-detection values, a significant p-




significant difference in the concentration of all enteric viruses in TT2, based on comparing raw 
sewage and SWIFT water effluent.  
One of the objectives of the project was to assess the concentrations of infectious human 
enteric viruses at the end of each treatment train in relation to the initial concentrations of 
human enteric viruses. To make this comparison, a Wilcoxon rank sum test was also performed 
on the concentrations of all enteric viruses in the raw sewage and final effluent of TT1. The 
reported p-value (p-value = 0.25) is not significant, thus, indicating that the null hypothesis is 
not rejected and that the concentration of all enteric viruses is not significantly different. 
between the raw sewage starting point and final treated effluent end point of TT1. 
A Kruskal-Wallis test was performed to determine if there are any statistical differences in the 
median concentration of all viruses between the initial raw sewage sample, the final 
wastewater treatment train effluent sample, and the SWIFT sample. The Kruskal-Wallis test 
employed when including non-detection values is significant (p-value = 1.00x10-6). Based on a 
post-hoc Dunn analysis of sample pairs of enteric virus concentrations, there is a significant 
difference in median concentration of all enteric viruses between the raw sewage and SWIFT 
samples (p-value = 2.95x10-6), and between the final wastewater treatment plant effluent and 
the SWIFT samples (p-value = 6.04x10-5). When controlling for the effect of non-detection 
values on the median virus concentrations by excluding them, a statistically significant p-value 
of 0.0036 is obtained. When a Dunn post-hoc statistical analysis is performed on sample pairs 
to reduce the type 1 error rate, there is a statistically significant difference between the median 




and between the final wastewater effluent and SWIFT samples (p-value = 0.048), when 
excluding virus non-detection values.  
The log10 concentrations of infectious adenoviruses found across all sampling points for the 5-
month study period is shown in figure 6. In general, adenovirus was found in the highest 
concentration in the raw sewage samples (sewage median = 2.35 Log10(MPN/100 mL), n=5). All 
of the secondary clarified samples tested also were positive for the detection of infectious 
adenovirus, but the concentrations were lower when compared to the raw sewage. A median 
Log10 concentration of 1.00 Log10(MPN/100 mL) (n=5) was reported for the secondary clarified 
samples. Both the final wastewater treatment plant effluent and SWIFT samples had a median 
concentration of less than 1 Log10 MPN/100 mL for the 5 samples analyzed (0.59 and -0.85 
Log10(MPN/100 mL), respectively). 
A Kruskal-Wallis test was employed to test for differences in the median concentration of 
adenovirus among the different wastewater and water samples analyzed. A p-value of 0.003 is 
reported and is considered significant at an alpha 0.05 level. Post-hoc Dunn analysis was done 
to determine which sample pairs have statistically significant differences in the concentrations 
of adenovirus. There were significant differences in virus concentrations for the sample pairs of 
secondary clarified wastewater and SWIFT (p-value = 0.031), and raw sewage and SWIFT (p-





Figure 6. Log10 (MPN/100mL) median concentrations of adenovirus in 5 monthly samples of raw 
sewage, secondary clarified effluent, final effluent and SWIFT reclaimed water. Error bars 
represent 95% confidence intervals. Concentrations are based on 6 replicates of 4 10-fold series 
dilutions. 
The median concentrations of infectious reovirus 5 monthly in raw sewage samples was found 
to be 0.51 Log10MPN/100 mL) (Figure 7). A median concentration of 0.59 Log10 MPN/100 mL 
was found in the 5 monthly secondary clarified wastewater samples. For final effluent samples, 
the average concentration of reovirus was found to be 0.51 Log10 MPN/100 mL in 5 monthly 
samples. The median concentration of reovirus in the SWIFT samples was reported to be -0.81 






































Figure 7. Log10 (MPN/100mL) concentration of infectious reovirus in 5 monthly samples of raw 
sewage, secondary clarified wastewater, final treated wastewater effluent and SWIFT reclaimed 
water. Error bars represent 95% confidence intervals. Concentrations are based on 6 replicates 
of 4 10-fold series dilutions. 
A Kruskal-Wallis test was used to determine statistical differences in median concentrations of 
reovirus between all sampling point and a statistically significant p-value of 0.0085 was 
obtained. A post-hoc Dunn analysis was done to determine which pairs of samples were 
significantly different. There were statistically significant differences in median concentration of 
reovirus between the sewage and SWIFT samples (p-value = 0.027); secondary clarified and 
SWIFT samples (p-value = 0.0088); and the final wastewater effluent and SWIFT samples (p-


































Infectious enteroviruses were not detected in any of the sample types in any of the sampling 
months using ICC-RT-PCR as shown by figure 8. Non-detection values were calculated to 
estimate reovirus concentrations these were used for all graphs and statistical testing. The 
median concentrations of enteroviruses in sewage, secondary clarified, and final effluent 
samples were computed to be less than 0.24 Log10 MPN/100 mL in the 5 monthly samples. The 
computed median concentration of enteroviruses was lower in the SWIFT sample, with a value 
of less than -0.80 Log10 MPN/100 mL in the 5 monthly samples.  
 
Figure 8. Log10 (MPN/100mL) concentrations of enteroviruses in 5 monthly samples of raw 
sewage, secondary clarified wastewater effluent, final wastewater effluent and SWIFT 
reclaimed water. All concentrations are less than values, based on the lower limits of virus 
detection and are represented by yellow arrows. Error bars represent 95% confidence intervals. 





































A Kruskal-Wallis test was also used to determine differences in the median concentration of 
enterovirus among the 4 sampling points. A p-value of 0.0040 is reported and is considered 
significant at a 0.05 alpha level. Based on a post-hoc Dunn analysis to determine significant 
differences in pairs of samples there were significant differences in the median concentrations 
of enterovirus between sewage and SWIFT samples (p-value = 0.014); secondary clarified 
wastewater and SWIFT samples (p-value = 0.0088); and final wastewater effluent and SWIFT 
samples (p-value = 0.014).  
Log10 Reduction Values of Infectious Adenovirus and Reovirus 
 
Figure 9 displays the log10 reductions in the concentration of adenovirus from the initial raw 
sewage sample to the final wastewater effluent sample or the SWIFT sample per sampling 
month. The average log10 reduction of adenovirus in the final effluent from the initial raw 
sewage was 2.49 for the 5 monthly samples. Similarly, the average log10 reduction of 
adenovirus in the SWIFT sample from the initial raw sewage was 2.55 for the 5 monthly 
samples.  
A Wilcoxon rank-sum test was used to determine if the difference in the median log10 reduction 
in the concentration of adenovirus between the final effluent sample and the final SWIFT 
sample was significant. There was a p-value of 0.674 and thus, at the 0.05 alpha level of 
significance, the null hypothesis was not rejected, indicating that there is no significant 
difference in the median log10 reduction between the 5 monthly final wastewater effluent 





Figure 9. Log10 reduction of adenovirus in final wastewater effluent and SWIFT reclaimed water 
samples from initial raw sewage samples for all 5 sampling periods. Upwards arrows indicate a 
reported value at the lower detection limit, suggesting that removal could be greater than what 
was calculated. Error bars represent 95% confidence intervals. 
Log10 reduction values for reovirus in final effluent and SWIFT samples from raw sewage are 
shown in figure 10 for 5 monthly samples. An average log10 reduction of 0.46 was reported for 
reovirus in the final effluent samples. The average log10 reduction for reovirus in the SWIFT 
reclaimed water samples was determined to be 0.66. The log10 reductions of reovirus for both 
treatment trains in this project resulted in less than 1 log10 removal of reovirus.  
To determine if there is a statistical difference in the removal of reovirus between the two 
treatment trains, a Wilcoxon rank-sum test was used for analysis of the median reductions 
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0.05, the null hypothesis is not rejected. This result suggests that there is no significant 
difference in the median log10 removals of reovirus between the two treatment trains. 
 
Figure 10. Log10 reduction of reovirus from 5 monthly raw sewage samples for final wastewater 
effluent and SWIFT reclaimed water samples of the two separate treatment trains. Upwards 
arrows indicate a reported value at the lower detection limit, suggesting that removal could be 





The purpose of the cytotoxicity experiments was to establish the effects of the concentration of 
the wastewater treatment plant samples to be assessed on the candidate cell lines and their 
ability to detect the target enteric viruses. An issue that arises when water samples are 
concentrated from a high volume of water or wastewater to a low volume is that interfering 
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establish any effects that may occur to the cell line from pasteurized samples to ensure that any 
visually identified CPE is from an active virus infection, and not from indigenous toxicity of the 
sample. Our findings suggested that within the samples analyzed, there was no significant 
cytotoxicity to the host cells. This finding is similar to that of Polston et al. (2014) in that they 
did not find any significant cytotoxicity with wastewater treatment plant samples in the G293 
cell line.  
Concentration of Target Human Enteric Viruses in Wastewater and Water Samples 
 
Human enteric viruses continue to be a source of sporadic gastroenteritis outbreaks worldwide. 
Because many of these enteric virus pathogens are excreted in the feces of infected humans, 
they tend to have high concentrations in raw sewage. The concentrations of human enteric 
viruses detected in the raw sewage samples of this study are similar to the concentrations 
found in other reported studies (Aulicino et al., 1996; Qiu et al., 2018; Rose, 2004; Sedmak et 
al., 2005).  
There are currently no regulations set by any governmental agency requiring the monitoring of 
human enteric viruses in wastewater before being discharged into a receiving body of water 
(Simmons & Xagoraraki, 2011). Wastewater treatment plants are not required to monitor the 
virological quality of their wastewater treatment plant effluent and thus, they could be 
introducing high concentrations of potentially infectious human enteric viruses into natural 
bodies of water.  This research provided the wastewater and water utility with new information 
regarding the concentrations of infectious human enteric viruses present within the effluent of 




Treatment train 1, the conventional wastewater treatment train, showed a decrease in the 
concentration of all enteric viruses. However, this decrease in concentrations of all enteric 
viruses was not significant when comparing the median concentrations of all enteric viruses 
between each treatment plant step analyzed in TT1. This indicates that while a general 
decrease in virus concentrations is obtained, this observed decrease does not result in a 
significant reduction of all enteric viruses during the treatment process. 
The mean concentration of human enteric viruses found in the raw sewage samples of this 
study are similar to the concentration of human enteric viruses detected in raw sewage 
samples in previous studies (Aulicino et al., 1996; Polston et al., 2014; Qiu et al., 2018; Rose, 
2004; Sedmak et al., 2005). A limitation of this present study is that the starting concentration 
of all enteric viruses for TT2 had to be estimated, given that we only received the raw sewage 
samples from the TT1 facility. However, because we found similar concentrations of human 
enteric viruses in our study as other studies, we have considered this to assumption to be valid 
for determining LRVs. 
A study by Simmons and Xagoraraki (2011) found higher concentrations of infectious human 
enteric viruses in their raw sewage, but reported similar concentrations of human enteric 
viruses in their secondary clarified and wastewater plant effluent samples. Additionally, the 
concentration of all human enteric viruses in the effluent of TT1 are similar to those reported 
by Sedmak et al. (2005). The concentration of human enteric viruses in the secondary clarified 
sample is within the range reported by Rose (2004), and they also found similar percent 
positivity scores in the detection of human enteric viruses in reclaimed water samples as 




In this study it was found that there were significant differences in the concentrations of human 
enteric viruses between the raw sewage influent of the wastewater treatment plant and the 
final SWIFT reclaimed product. Furthermore, this study also determined that there was a 
significant difference in the concentrations of human enteric viruses between the conventional 
wastewater plant effluent, and the pilot study SWIFT reclaimed water. This indicates that the 
additional treatment processes employed in the pilot facility helped achieve significant 
reductions in the median concentrations of human enteric viruses between the raw sewage 
influent, and between the final effluents of the two treatment trains.  
Adenovirus was the most commonly found virus in the raw sewage samples. This finding is in 
contrast with the previous findings that determined reoviruses to be more prevalent in raw 
sewage (Sedmak et al., 2005), but is consistent with findings reported elsewhere (Charles P 
Gerba et al., 2017; Katayama et al., 2008; Qiu et al., 2015). Percent positive scores for 
adenovirus raw sewage and effluent were similar to those reported by Hewitt, Leonard, 
Greening, and Lewis (2011). The percent positive rate for reovirus in raw sewage is similar to 
the findings reported by Aulicino et al. (1996), but they reported a higher percent positivity for 
reovirus in the final effluent than found  in this present study.  
Enteroviruses were not detected in any of the samples by ICC-RT-qPCR in this study. This is in 
contrast to the findings of a number of other studies (Aulicino et al., 1996; Qiu et al., 2015).  
There is evidence to suggest that the cell line used to study enteroviruses, the BGM cell line, is 
not as sensitive to infection by enterovirus as other cell lines (Grabow, Botma, de Villiers, & 
Erasmus, 1999; Rodríguez, Gundy, & Gerba, 2008). Using this cell line could have led to an 




Future ICC-RT-qPCR studies involving the detection of enteroviruses in sewage samples should 
consider the use of the primary liver carcinoma (PLC/PRF/5) cell line to ensure greater 
sensitivity in detecting and quantifying enteroviruses (Rodríguez et al., 2008).   
In this study, significant differences were found in the concentrations of adenoviruses, 
enteroviruses, and reoviruses between the initial raw sewage samples and the final SWIFT 
reclaimed water samples. This result suggests that the pilot scale water reclamation treatment 
train was effective in significantly decreasing the median concentrations of each of these 
viruses from the initial concentrations in the raw sewage influent to the pilot SWIFT final 
reclaimed water effluent intended for potable reuse.  
Log10 Reduction Values  
 
There are currently no federal regulations or guidelines that require the monitoring of human 
enteric virus concentrations leaving a wastewater treatment plant as effluent. To address this 
concern, the EPA has reviewed the use of coliphages as indicators of enteric viruses for ambient 
water quality (EPA, 2015). Rose (2004) evaluated the degree to which human enteric viruses 
were removed/inactivated through wastewater treatment and reclamation facilities in the US 
and reported similar reductions of human enteric viruses for steps in a wastewater treatment 
facility that are similar to the one studied in this report. Asano et al. (2007) also reported a 
range of log10 reduction values experienced during secondary treatment of human enteric 
viruses that are consistent with those found in this report.  
For TT1, the reported log10 reductions for adenovirus are similar to those found in previous 




studies assessed the removal of adenovirus from urban wastewater plants, and employed 
similar disinfection strategies used by the wastewater treatment plant assessed in this study. 
The data for the log10 reductions of infectious adenovirus in TT1 provides the sanitation district 
with new information regarding the removal of infectious adenovirus that is consistent with 
findings previously documented.  
There are currently no consistent federal guidelines or regulations on log10 reduction 
performance targets for viruses. As such, most of the regulations on log10 performance targets 
have been set by local States and can vary greatly. California, for example, has set a required 
12-log10 reduction performance target for viruses, while North Carolina has set a required 5-
log10 reduction target (North Carolina General Assembly, 2014; Title 22 and 17 California Code 
of Regulations State Board, 2015).  This study compared the reported LRVs of the pilot 
reclamation plant to the targeted log10 reduction regulations set by California and North 
Carolina.  
Many reclaimed water facilities employ membrane filtration as a treatment step in the 
reclaimed water treatment train. However, the pilot facility assessed in this study employed a 
combination of granular activated carbon filtration and UV disinfection (186 J/cm2). Few studies 
have been conducted to assess the ability of a treatment train similar to the one studied here 
to remove infectious human enteric viruses from reclaimed water intended for potable reuse. A 
similar study assessing a possible reclaimed water treatment train that does not include 
membrane filtration detected similar, but slightly lower, log10 reduction values calculated for 




The reported LRVs for the pilot reclaimed water treatment train (TT2) for adenovirus and 
reovirus (2.55 and 0.66, respectively) are well below the required 12-log10 reduction of viruses 
for potable reuse set by California. However, most water reclamation plants in California 
employ the use of membrane filtration, which can achieve between 2.4-6.5 log10 units of 
reduction for viruses (Soller, Eftim, & Nappier, 2018). The pilot plant assessed in this study did 
not include the use of membrane filtration. North Carolina has set regulations for recycled 
water intended for potable reuse that does not require the use of membrane filtration. In these 
regulations, a 5-log10 reduction in coliphage indicators for viruses is required. However, the 
infectious human enteric virus LRVs reported here do not meet those requirements and are 
similar to the findings reported by Bailey et al. (2018), where candidate water reuse systems 
without membrane filtration treatment was assessed.  
This study found that the pilot reclaimed water treatment train did not achieve the required 
necessary LRVs for reclaimed water intended for potable reuse that has been set by California 
and North Carolina. The implementation of other virus removal and inactivation technologies is 
recommended to further decrease the concentration of human enteric viruses. Technologies 
such as high dose UV (800 mJ/cm2), ozonation, and membrane filtration have been shown to be 









▪ There was a significant difference in the median concentrations of human enteric 
viruses between the raw sewage influent and the SWIFT reclaimed water samples of this 
study. 
▪ There was a significant difference in the median concentrations of human enteric 
viruses between the conventional wastewater treatment plant train and the pilot 
reclaimed water treatment train.  
▪ The reported LRVs for the reclaimed water intended for potable reuse do not meet the 
12-log10 reduction performance target set by California, nor do they meet the 5-log10 
reduction performance target set by North Carolina. There are currently no 
performance targets for treated wastewater intended for potable reuse that have been 
set by Virginia 
▪ The fully operational reclaimed water plant site to be built by the Hampton Roads 
Sanitation District should include additional viral removal/inactivation technologies, if 
the virus reductions achieved in this pilot reclaimed water treatment trains are also 
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